Market Place
Sourcing Support
Zai Lab & Pfizer Announce Collaboration on Antibacterial Drug
21 Nov 2024 //
BUSINESSWIRE
Zai Lab, Innoviva`s SUL-DUR Approved In China For Pneumonia
20 May 2024 //
BUSINESSWIRE
Innoviva Specialty Therapeutics Announces FDA Approval for XACDURO
23 May 2023 //
BUSINESSWIRE
Results from Phase 3 ATTACK Trial Published in The Lancet Infectious Diseases
11 May 2023 //
BUSINESSWIRE
FDA panel backs Innoviva`s drug for multidrug-resistant bacterial infections
18 Apr 2023 //
REUTERS
Sulbactam-Durlobactam Unanimously Recommended for Approval by FDA
17 Apr 2023 //
BUSINESSWIRE
Innoviva Announces FDA Acceptance and Priority Review of NDA for (SUL-DUR)
30 Nov 2022 //
BUSINESSWIRE
Entasis Presents Data on Sulbactam-Durlobactam & ETX0462 at 2022 ASM
09 Jun 2022 //
GLOBENEWSWIRE
Entasis antibiotic beats last resort treatment in phase 3 trial
20 Oct 2021 //
YAHOOFINANCE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.